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Abstract
Alpha-melanocyte-stimulating hormone (α-MSH) is a potent anti-inflammatory peptide with
cytoprotective effect in various tissues. The present investigation demonstrates the ability of
α-MSH to interact with intestinal epithelial cell monolayers and mitigate inflammatory pro-
cesses of the epithelial barrier. The protective effect of α-MSH was studied on Caco-2
human intestinal epithelial monolayers, which were disrupted by exposure to tumor necrosis
factor-α and interleukin-1β. The barrier integrity was assessed by measuring transepithelial
electric resistance (TEER) and permeability for marker molecules. Caco-2 monolayers were
evaluated by immunohistochemistry for expression of melanocortin-1 receptor and tight
junction proteins ZO-1 and claudin-4. The activation of nuclear factor kappa beta (NF-κB)
was detected by fluorescence microscopy and inflammatory cytokine expression was
assessed by flow cytometric bead array cytokine assay. Exposure of Caco-2 monolayers to
proinflammatory cytokines lowered TEER and increased permeability for fluorescein and
albumin, which was accompanied by changes in ZO-1 and claudin-4 immunostaining. α-
MSH was able to prevent inflammation-associated decrease of TEER in a dose-dependent
manner and reduce the increased permeability for paracellular marker fluorescein. Further
immunohistochemistry analysis revealed proinflammatory cytokine induced translocation of
the NF-κB p65 subunit into Caco-2 cell nuclei, which was inhibited by α-MSH. As a result the
IL-6 and IL-8 production of Caco-2 monolayers were also decreased with different patterns
by the addition of α-MSH to the culture medium. In conclusion, Caco-2 cells showed a posi-
tive immunostaining for melanocortin-1 receptor and α-MSH protected Caco-2 cells against
inflammatory barrier dysfunction and inflammatory activation induced by tumor necrosis fac-
tor-α and interleukin-1β cytokines.
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Introduction
Epithelial cells are key components of the intestinal barrier by forming tight junctions (TJ)
sealing the paracellular cleft, thus restricting free flux of cells and molecules from the gut to the
blood. Dysfunction of the epithelial barrier is a common feature in inflammatory diseases of
the gastrointestinal system [1]. The damage of the protective epithelial barrier contributes to
the pathomechanism and both local and systemic inflammation. Proinflammatory cytokines
tumor necrosis factor-α (TNF- α) and interleukin-1β (IL-1 β) are overexpressed in inflamma-
tory bowel diseases and directly damage the intestinal barrier including the interepithelial TJs
[1]. Cell culture models of intestinal epithelium are widely used in the characterization of gut
disease pathomechanisms, and to evaluate selected pharmacotherapies. The Caco-2 human
intestinal epithelial cell line is a well-characterized model to study intestinal absorption pro-
cesses [2], and is also used to investigate intestinal inflammation [3–6].
Since TNF-α and IL-1β are pathogenic factors in intestinal inflammation, they are used in
both animal and culture models to induce epithelial cell inflammation and barrier opening.
These cytokines induce initiation and amplification of inflammatory cellular processes which
alter Caco-2 function, such as cell layer permeability, in ways that can be used as the model of
inflamed bowel epithelium [7–9]. Treatment of Caco-2 cells with TNF-α or IL-1β decrease the
electrical resistance of monolayers and increase IL-8 production indicating epithelial barrier
opening and inflammatory response [8,10,11]. In our previous study we described, that claudin-
4, a sealing claudin, is the most expressed member of the claudin family after claudin-1 in Caco-
2 cells [12]. Claudin-4 was described as an important element of the intestinal barrier in both
colon tissue of mice and Caco-2 cells with a significant downregulation in inflammation [13].
A prominent member of the melanocortin system, α-MSH, regulates crucial aspects of not
only melanogenesis but also inflammation in various cell types [14]. The antiinflammatory
effects of α-MSH are mediated by the inhibition of NF-κB induced inflammatory processes,
like activation and proliferation of lymphocytes, and proinflammatory cytokine production
[15,16]. Due to this protective action the therapeutical potential of α-MSH has been widely
examined in immune-mediated pathologies, like allergic and inflammatory diseases of the skin
and lung, ocular inflammation, arthritis, and inflammatory bowel disease [16]. The antiinflam-
matory effects of α-MSH have been examined in animal models of intestinal injury. In a rat
model of chemically induced acute and chronic colitis α-MSH reduced pathological weight
loss, fecal blood, TNF-α and nitric oxide production in colon tissue [17] and macroscopic coli-
tis lesions [18]. Protective effect of α-MSH was also described in rat models of intestinal ische-
mia/reperfusion, where NF-κB induced inflammation has a central role in the
pathomechanism [19,20].
The immunomodulatory action of α-MSH is regulated by melanocortin receptors MC1,
MC3, MC4 and MC5 [16]. The presence of MC1R, the most important receptor responsible
for mediating the antiinflammatory effects of α-MSH, was demonstrated on intestinal epithe-
lium in mice [21]. The crucial role of this receptor in inflammatory gut disease was demon-
strated in sophisticated mouse models, where the absence of a functional MC1R resulted in the
aggravation of different types of experimental colitis indicating the protective role of the α-
MSH-MCR1 pathway on non-hematopoietic cells [21].
Based on these data we hypothesized a direct protective action of α-MSH on cytokine-
induced barrier dysfunction and inflammatory activation in the human Caco-2 epithelial cell
line, which has not been investigated, yet. Therefore the aims of the present study were: (i)
demonstration of the presence of MC1R on Caco-2 epithelial cells, (ii) testing the effects of α-
MSH on TNF-α and IL-1β treatment induced barrier damage by measurement of transepithe-
lial electric resistance (TEER) and permeability for marker molecules, and visualization of TJ
Melanocyte Stimulating Hormone Protects Caco-2 Epithelial Cells
PLOS ONE | DOI:10.1371/journal.pone.0170537 January 19, 2017 2 / 14
Competing Interests: The authors confirm that
there are no conflicts of interest with respect to any
of the topic material presented herein.
proteins ZO-1 and claudin-4, (iii) investigating the inhibitory action of α-MSH on cytokine-
induced inflammatory response, including NF-κB nuclear translocation, and polarized secre-
tion of proinflammatory cytokines IL-6 and IL-8.
Materials and Methods
Materials
All reagents were purchased from Sigma-Aldrich Corporation (subsidiary of Merck KGaA,
Darmstadt, Germany) unless otherwise indicated.
Cell culture
Human Caco-2 intestinal epithelial cells (#86010202) purchased directly from European Col-
lection of Authenticated Cell Cultures, UK, were cultured in Dulbecco’s Minimum Essential
Medium (DMEM) supplemented with 10% fetal bovine serum [22]. Cell monolayers (10–40
passages) were grown on permeable polycarbonate inserts (Transwell1, Corning, Lowell, MA,
USA; 0.4 μm pore size, 1.12 cm2 surface) in CO2 incubator at 37˚C. Cell seeding density was
2 × 105 cells/insert. Culture medium was replaced with fresh medium every two or three days.
During the 21-day culture period Caco-2 cells formed fully differentiated, confluent monolay-
ers with apical-basal polarization. Differentiated and polarized cell layers showing high TEER
values were used for experiments, as described in our previous study [23].
Treatments
To induce barrier damage differentiated Caco-2 cell cultures were treated with a combination
of the proinflammatory cytokines TNF-α (50 ng/ml) and IL-1β (25 ng/ml) for 24 hours. The
control group received culture medium only (negative control). To test the protective effect of
α-MSH the following concentrations were used: 10−4 M, 10−8 M, 10−12 M, 10−16 M.
Measurement of transepithelial electrical resistance
The formation of tight paracellular barrier in Caco-2 layers was monitored by the development
of high transepithelial electrical resistance (TEER) and measured with Millicell-ERS volt-ohm
meter (Millipore, USA) using chopstick electrodes. Resistance was expressed to the surface of
the Transwell filters (O × cm2) and the TEER of cell-free inserts was subtracted from these
values.
Measurement of permeability for marker molecules
Cell culture inserts (surface: 0.33 cm2) containing confluent and differentiated Caco-2 cells
were transferred to plates containing 530 μl Ringer-Hepes buffer (150 mM NaCl, 2.2 mM
CaCl2, 0.5 mM MgCl2, 5.2 mM KCl, 6 mM NaHCO3, 2.8 mM glucose and 5 mM Hepes, pH
7.4) in the basal (lower) compartments. In the apical (upper) compartments culture medium
was replaced by 70 μl buffer containing albumin (10 mg/ml; Mw: 67 kDa) in complex with
Evans blue (167.5 μg/ml) and sodium fluorescein (10 μg/ml, Mw: 376 Da). The plates were
kept at 37˚C in an incubator with 5% CO2 for 1 hour on a rocking platform (100 rpm). After
the incubation samples from the upper and lower compartments were collected and the con-
centrations of the marker molecules were determined by a fluorescence multiwell plate reader
(Fluostar Optima, BMG Labtechnologies, Germany; excitation wavelength: 485 nm, emission
wavelength: 535 nm for fluorescein and excitation wavelength: 584 nm, emission wavelength:
680 nm for Evans-blue labeled albumin). The apparent permeability coefficients (Papp) were
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calculated by the following equation [24].
Papp ¼
½CB  VB
A ½CA  t
where [C]B is the concentration of the tracer in the basal (acceptor) compartment after 1 hour,
[C]A is the concentration of the tracer in the apical (donor) compartment at 0 hour, VB is the
volume of the basal compartment (530 μl) and A is the surface area available for permeability
(0.33 cm2).
Immunohistochemistry
Melanocortin-1 receptor. Caco-2 cell monolayers grown on polycarbonate filters were
washed in phosphate buffered saline (PBS) and fixed with 4% paraformaldehyde solution
for 20 minutes. Cell membranes were permeabilized with 0.2% Triton-X for 10 minutes.
Non-specific binding sites were blocked with FBS for 30 minutes. A rabbit anti-human
MC1R antibody (M9193 Sigma-Aldrich, AB_212630, 1 mg/ml) was used for primary label-
ling of the target antigen, followed by secondary labelling with Alexa Fluor 488 conjugated
to goat-anti-rabbit IgG (A-11008, Thermo Fisher Scientific, Waltham, MA, USA,
AB_143165, 2 mg/ml). Cell nuclei were labelled with propidium iodide. The samples were
thoroughly washed with PBS after each step. Stainings were visualized by an Olympus
FV1000 confocal microscope using an UPLSAPO 60× (NA 1.35) oil immersion objective.
Excitation of Alexa Fluor 488 (conjugated to anti-MC1R) was accomplished using the 488
nm line of an Ar ion laser; with an emission spectrum of 500–530 nm. Excitation of propi-
dium iodide was done using a 543 nm HeNe laser, with an emission spectrum of 555–635
nm. Excitation of Alexa Fluor 647 (labeling anti-MHC I W6/32 mAb) was done using a 633
nm HeNe laser, with an emission spectrum of 655-755nm. Line-by-line alternating illumi-
nation with the different lasers was used to minimize crosstalk. Images (256×256-pixels;
pixel size: 0.103 μm; pixel time: 4 μs) were collected and 4× averaging was applied to reduce
background noise. Image stacks were recorded with a step size of 0.8 μm and an optical slice
thickness of 0.88 μm (pinhole: 93 μm). Projection images of three adjacent optical sections
were generated at the basal and at the apical side of the cells using the FV1000 software for
the microscope. 3D image reconstructions of the cells were generated from image stacks.
Transverse views of cells were used to visualize receptor expression levels of the apical and
basal cell surfaces.
ZO-1 and claudin-4 tight junction proteins and nuclear factor kappa B
(NF-κB) activation
For these experiments, Caco-2 cells were seeded onto sterile uncoated microscope slides at a
density of 5 × 104 cells/slide, and cultured until the formation of monolayers. Caco-2 cultures
were divided into three groups: the first group received culture medium only and served as
negative controls. The second group was treated with IL-1β and TNF-α; and the third group
received 10−8 M α-MSH in addition to cytokines. Treatments lasted 24 hours for the tight
junction protein stainings, and for 30 minutes for p65 protein immunostaining, which is an
indicator of NF-κB activation and nuclear localization. For ZO-1 and claudin-4 immunostain-
ings cells were fixed and permeabilized with acetone/methanol 1:1. Primary staining was
accomplished using rabbit anti-human ZO-1, or claudin-4 antibodies (40–2200 and PA5-
16875, AB_2533456 and AB_10978522, 0.5 μg/ml), followed by secondary labelling with Alexa
Fluor 488 conjugated goat-anti-rabbit IgG (all antibodies from Thermo Fisher Scientific, MA
USA). For p65 staining cells were fixed with ice-cold methanol-acetone (50 v/v %) for 10
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minutes. Nonspecific antibody binding sites were blocked with FBS for 15 minutes. For pri-
mary labelling of NF-κB p65 subunit rabbit anti-human p65 (sc-372, Santa Cruz Biotechnol-
ogy, AB_632037, 100 μg/ml) was used followed by secondary staining with Alexa Fluor
488-conjugated goat-anti-rabbit IgG and Hoechst 33342. For both TJ proteins and NF-κB
stainings samples were observed by Zeiss Axio Scope.A1 fluorescent microscope (HBO 100
lamp) (Carl Zeiss Microimaging GmbH, Go¨ttingen, Germany). Images were analyzed with
ZEN 2012 v.1.1.0.0. software (Carl Zeiss Microscopy GmbH, Go¨ttingen, Germany), and for
the NF-κB stainings the ratio of nuclear and perinuclear fluorescence intensity was calculated.
Specificity of all immunostainings was checked by incubating the cells with secondary antibod-
ies only, and no background stainings were found.
Flow cytometric bead array cytokine assay
Production of the inflammatory cytokines IL-6 and IL-8 by Caco-2 cells were measured in cell
culture medium using the multiplexed flow cytometric bead array (CBA) Human Inflamma-
tory Cytokines Kit (BD Biosciences, San Jose, CA, USA). For this assay 50 μl culture medium
samples were collected at 4 and 24 hours timepoints from the apical and basal compartments
of culture inserts with confluent Caco-2 monolayers treated with culture medium, cytokines
and /or α-MSH. The CBA kits were used according to the manufacturer’s instructions. The
collected samples were diluted 2 times in the kit’s assay buffer. Diluted samples or appropriate
cytokine standards (50 μl) were added to equal amounts of fluorescent cytokine capture bead
suspension (50 μl), and human inflammatory cytokine-phycoerythrin detection reagent
(50 μl) on multi-well filter microplates. The plates were incubated for 2 hours on a microplate
shaker at room temperature, followed by washing with a vacuum filtration manifold. To each
well 120 μl assay buffer was added and cytokine content of each sample was measured by
FACS array cytometry (BD Biosciences). Outcome data were analyzed using Flow Cytomix
Pro 2.3 software.
Statistical analysis
For statistical analysis SigmaStat software (version 3.1; SPSS Inc.) and GraphPad Prism 5.0
software (GraphPad Software Inc., USA) were used. Data are presented as means±S.D. Com-
parison of groups was performed using ANOVA and Dunnett or Bonferroni tests.
Differences were considered significant at P<0.05.
Results
Expression of melanocortin-1 receptor on Caco-2 cells
MC1R expression was detectable on both the apical and basal membranes of differentiated
Caco-2 cells in confluent monolayers by immunohistochemistry (Fig 1). The fluorescent
immunolabeling was more pronounced on the apical side, as compared to the staining at the
basal surface, where the red-stained cell nuclei were situated. This difference between the stain-
ing intensity was also visualized by the image of a horizontal section of a representative conflu-
ent Caco-2 cell monolayer.
Effect of cytokines and α-MSH on Caco-2 barrier integrity: transepithelial
electrical resistance
Differentiated Caco-2 monolayers expressed high TEER (700 O × cm2, n = 24) indicating a
tight paracellular barrier. Treatment with a combination of TNF-α and IL-1β cytokines
decreased the resistance of Caco-2 monolayers (P<0.001; Fig 2). A concentration dependent
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Fig 1. Melanocortin-1 receptor (MC1R) expression in Caco-2 cells. Cells were grown into confluent monolayers for 21
days on culture inserts and immunostained for MC1R. Nuclei were labeled with propidium iodide. Optical sections
prepared by a confocal microscope show MC1R expression levels at the apical and basal surfaces, and a digitized
horizontal section of the cells. Green: MC1R labeling; red: cell nuclei. Scale bar: 5 μm.
doi:10.1371/journal.pone.0170537.g001
Fig 2. The effect of different concentrations of α-MSH on the electrical resistance of cytokine treated Caco-2 monolayers. Caco-2
monolayers grown on culture inserts were treated with cytokines (CK; 50 ng/ml TNF-α and 25 ng/ml IL-1β) without or with different
concentrations of α-MSH (10−4 M, 10−8 M, 10−12 M, and 10−16 M) for 24 hours. The control group (C) received culture medium.
Transepithelial electrical resistance (TEER) values are shown as percentage of untreated control. Means ± S.D., n = 3; ***P < 0.001,
*P < 0.05, ###P<0.001. *: CK, CK+MSH compared to C; #: CK+MSH compared to CK.
doi:10.1371/journal.pone.0170537.g002
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effect of α-MSH was observed: the 10−4 and 10−8 M concentrations of α-MSH protected
against the cytokine-induced barrier disruption (P<0.001), while smaller concentrations had
no effect. For further experiments the most effective, 10−8 M concentration of α-MSH was
selected.
Effect of cytokines and α-MSH on Caco-2 barrier integrity: permeability
for marker molecules
A low permeability for both small marker fluorescein (1.71 ± 0.17 × 10−7 cm/s) and large bio-
molecule albumin (0.63 ± 0.39 × 10−7 cm/s) was measured on the epithelial monolayers. Cyto-
kine treatment significantly enhanced the permeability of the Caco-2 cell layers for both
markers (Fig 3). The α-MSH peptide (10−8 M) significantly blocked the barrier opening effect
of the cytokines for fluorescein.
Effect of cytokines and α-MSH on Caco-2 barrier integrity: localization of
TJ proteins ZO-1 and claudin-4 by immunofluorescence microscopy
The tight paracellular barrier of Caco-2 cells was also demonstrated by the localization of inte-
gral membrane TJ protein claudin-4 and cytoplasmic linker protein ZO-1, which appeared at
the cell-cell borders in a continuous, belt-like manner (Fig 4). In the control group cell-cell
attachment in the monolayers was continuous, without gaps. In cytokine treated cells the pat-
tern of the staining changed: intercellular gaps, fragmented junctional staining and cyto-
plasmic redistribution of junctional proteins were observed. The immunostaining pattern of
TJ proteins in epithelial cells treated with α-MSH was similar to the control group.
Effect of α-MSH on cytokine-induced NF-κB nuclear translocation in
Caco-2 cells
Translocation of the p65 NF-κB subunit into cell nuclei is a reliable measure of the intensity of
an inflammatory reaction at the cellular level. To further analyze the potential effects of α-
MSH early NF-κB nuclear translocation was investigated in Caco-2 cells following short term
(30 minutes) cytokine treatment (Fig 5A). Inflammatory cytokines induced the appearance of
green-stained p65 within nuclei of Caco-2 cells. The nucleus/cytosol intensity ratios of green
Fig 3. The effect of α-MSH treatment on the permeability of cytokine treated Caco-2 monolayers. Caco-2 monolayers grown on
culture inserts were treated with cytokines (CK; 50 ng/ml TNF-α and 25 ng/ml IL-1β) without or with α-MSH (10−8 M) for 24 hours, then
permeability was measured for fluorescein (A) and albumin (B). The control group (C) received culture medium. Means ± S.D., n = 4–6;
***P < 0.001, #P < 0.05. Papp, apparent permeability coefficient. *: CK, CK+MSH compared to C; #: CK+MSH compared to CK, ns: no
significant difference to C or CK.
doi:10.1371/journal.pone.0170537.g003
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channel fluorescence provide a numerical display of the cytokine effect [25] with low ratios
corresponding to control cells. The increased ratio of signal intensity, combined with co-locali-
zation of green and blue signals, reflects inflammatory cytokine-mediated nuclear transloca-
tion of p65. The NF-κB nuclear translocation indicated by high nucleus/cytoplasm intensity
ratio observed after cytokine treatment was significantly inhibited by 10−8 M α-MSH (Fig 5B).
Fig 4. The effect of α-MSH treatment on the immunostaining of tight juntion proteins claudin-4 and ZO-1 in
cytokine treated Caco-2 cells. Caco-2 cells were treated with cytokines (CK; 50 ng/ml TNF-α and 25 ng/ml IL-1β) without
or with 10−8 M α-MSH (CK+MSH) for 24 hours, then immunostained for integral membrane tight junction protein claudin-4
and cytoplasmic linker protein ZO-1. The control group (C) received culture medium. The fluorescent microscopy images
demonstrate the expression and organization of the junctional proteins. Scale bar: 10 μm.
doi:10.1371/journal.pone.0170537.g004
Fig 5. Immunohistochemical staining and analysis of NF-κB activation in cytokine- and α-MSH-treated Caco-2 cells. (5A) Caco-2 cells were
treated for 30 minutes with culture medium (C), cytokines (CK; 50 ng/ml TNF-α and 25 ng/ml IL-1β), or cytokines and 10−8 M α-MSH (CK+MSH).
Nuclear localization of the NF-κB p65 subunit was monitored by immunostaining. Cell nuclei were labeled with Hoechst 33342. Green: p65 staining;
blue: cell nuclei. Scale bar: 10 μm. (5B) Ratio of the fluorescence intensity of the NF-κB immunostaining in cell nuclei and cytoplasm. Means ± S.D.,
n = 8–10, ***P < 0.001, **P<0.01, ###P<0.001. *: CK, CK+MSH compared to C; #: CK+MSH compared to CK.
doi:10.1371/journal.pone.0170537.g005
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Effect of cytokines and α-MSH on polarized release of IL-6 and IL-8 from
Caco-2 cells
In comparison to unstimulated control cultures, cytokine treatment resulted in significant ele-
vation of IL-6 release into the apical compartments, along with significant α-MSH-dependent
suppression of this effect (P<0.001) at both 4- and 24-hour time points (Fig 6A). No statistical
difference was observed in cytokine expression increase, or in α-MSH-mediated inhibition of
this increase between the 4- and 24-hour measurements (Fig 6A). Apical cytokine-induced
release of IL-8 increased significantly at both time points relative to the control group, but IL-8
production measured in medium samples collected apically at the 24-hour time point was ele-
vated more than 5-fold (P<0.001) relative to that at 4 hours (Fig 6B), but α-MSH had no effect
(Fig 6B). Cytokine-induced release of IL-6 and IL-8 into the basal compartments occurred
according to a somewhat different pattern from that of the apical medium: although IL-6
release to the basal compartment significantly exceeded that of untreated control cultures
(P<0.05) (Fig 6C), with no significant difference noted between the 4- and 24-hour time
points, α-MSH treatment failed to suppress the basolateral release of IL-6 (Fig 6C). Similarly to
Fig 6. Secretion of IL-6 and IL-8 in Caco-2 cells treated with cytokines and α-MSH. Caco-2 monolayers grown on culture inserts were
treated with cytokines (CK; 50 ng/ml TNF-α and 25 ng/ml IL-1β) without or with α-MSH (10−8 M) for 4 and 24 hours. The control group (C)
received culture medium. Culture medium samples were collected from the apical and basal compartments. The concentration of IL-6 (6A
and 6C) and IL-8 (6B and 6D) secreted by Caco-2 cells were measured by multiplexed flow cytometric bead array assays. Means ± S.D.,
n = 3–5, ***P < 0.001, *P < 0.05; a: CK, CK+ MSH compared to C, P < 0.001; b: CK+ MSH compared to CK, P < 0.001 [1].
doi:10.1371/journal.pone.0170537.g006
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apical IL-8 expression responses, cytokine-induced production of IL-8 by Caco-2 monolayers
measured from the basal compartments was significantly increased relative to control cells at
both the 4-hour and 24-hour time points, but significantly greater at 24 hours (P<0.001) (Fig
6D). α-MSH treatment significantly reduced IL-8 expression at 24-hour time points
(P<0.001) (Fig 6D).
Discussion
The goal of the present study was to evaluate the protective effect of α-MSH on proinflamma-
tory cytokine-induced Caco-2 monolayer activation and barrier injury.
We demonstrated the polarized expression of MC1R on human Caco-2 epithelial cells with
a predominant apical localization (Fig 1) for the first time. Our results are in agreement with
the data of Maaser et al. who described the constitutive expression of MC1R protein in mouse
intestinal epithelial cells [21]. The presence of this receptor provides the basis for the hypothe-
sized direct action of α-MSH on epithelial cells.
A combination of the two most important pro-inflammatory cytokines in gut diseases
opened the paracellular barrier in Caco-2 monolayers for both ions measured by TEER (Fig 2)
and marker molecules fluorescein and albumin (Fig 3) indicating that there is a barrier leakage
for large biomolecules, too. The concentrations of TNF-α and IL-1β were proven to induce
barrier damage in Caco-2 cells in previous studies [10,8]. We observed a protective effect of α-
MSH against cytokine-induced resistance decrease with a maximal effect at the concentration
of 10−8 M. This concentration of α-MSH is similar to the concentrations which proved to be
effective on other cell types [14,26] and in animal experiments [19,27,28]. The 10−8 M concen-
tration of α-MSH we found the most effective corresponds to the physiological plasma concen-
tration of the hormone in humans [29] and in newborn pigs [30]. We also found, that α-MSH-
mediated barrier protection is not directly proportional to concentration of the hormone. It
was demonstrated earlier that α-MSH, like other peptide hormones, can show bell-shape dose-
response curve [31] similarly to our findings. The α-MSH concentration that prevented the
drop in TEER was also protective against paracellular barrier opening for fluorescein (Fig 3).
Data showing that an α-MSH related tripeptide blocked the reduced TEER induced by cyto-
kines on T84 monolayers, another human intestinal cell line, supports our findings [32].
Since TJ proteins seal the intercellular gaps in epithelial barriers, the disruption of Caco-2
monolayers was also reflected at the level of cell-cell interactions. Two membrane-associated
TJ proteins, ZO-1 and claudin-4, were used as representative TJ components. In concordance
with the functional measurements of barrier opening, cytokine treatment caused a decreased
immunostaining at cellular borders, where punctate and discontinuous staining was observed
(Fig 4). In our previous work we also demonstrated morphological changes at cellular junc-
tions in parallel with opening of the paracellular cleft in Caco-2 cells by TJ modulator peptides
[12]. In agreement with our observations claudin-4 was described to promote barrier function
in different cell cultures, and proinflammatory cytokines decreased its junctional presence and
increased the proportion of mobile claudin-4 in the TJ of Caco-2 cells [33,34]. Importantly,
claudin-4 expression is downregulated in intestinal biopsies of patients with ulcerative colitis
[35], indicating the potential clinical significance of the experimental observations.
The mechanisms that mediate the effect of the proinflammatory cytokines TNF-α and IL-
1β on intestinal barrier functions are well studied [7,9,36]. Earlier investigations verified that
TNF-α-induced increase in Caco-2 TJ permeability is associated with downregulation of ZO-1
protein expression and alteration in ZO-1 junctional localization. This intracellular process is
mediated by NF-κB activation [36]. IL-1β also causes NF-κB activation in Caco-2 cells leading
to increased MLCK mRNA and protein expression resulting in elevated junctional
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permeability [9]. The role of the NF-κB-MLCK pathway was also demonstrated in TNF-α
induced TJ opening in Caco-2 monolayers [37]. In the presence of α-MSH we found that the
damaging effect of cytokines on TJ morphology was attenuated. Our data are supported by
another study where α-MSH prevented the cytokine-induced redistribution of TJ proteins and
the opening of the barrier by NF-κB inhibition [14]
Translocation of the NF-κB p65 subunit into cell nuclei is a key event in inflammatory reac-
tions and epithelial barrier opening at the level of signaling pathways [8,38,39]. We could con-
firm in our study that cytokine treatments induced NF-κB nuclear translocation in Caco-2
epithelial cells, which was inhibited by α-MSH (Fig 5). These results further strengthen the
role of αMSH as a potent antiinflammatory molecule [5,14] which exerts its effect by inhibi-
tion of the NF-κB transcription factor. Indeed, NF-κB inhibition was found to be central in
the protective effect of α-MSH against oxidative stress in IEC-6 rat intestinal cells [40] and
against ischemia/reperfusion induced intestinal injury in rats [19,20].
As a downstream effect of NF-κB activation epithelial cells can secrete cytokines in inflam-
matory conditions further exacerbating gut barrier injury [20]. We found elevated secretion of
IL-6 and IL-8 inflammatory cytokines in Caco-2 cells treated with TNF-α and IL-1β (Fig 6).
The increased expression of these cytokines was also described in both cultured intestinal cells
after inflammatory stimulation [5,6,8] and in a rat model of intestinal injury [20]. We observed
that the cytokine-induced IL-6 and IL-8 production was vectorial, with significantly greater
apical secretion. The differences between apical and basal IL-6 and IL-8 release from Caco-2
cells are consistent with the results of other investigators [11,5]. Treatment with α-MSH inhib-
ited the apical secretion of IL-6 and the basal release of IL-8. Other studies also support this
inhibitory action of α-MSH. KPV, an α-MSH related tripeptide, reduced IL8 expression in
Caco-2-BBE cells stimulated by IL-1β [5] or LPS [6]. Notably, KPV and KdPT tripeptides
derived from α-MSH were protective not only on injured Caco-2 cultures, but also in mouse
and rat models of colitis [32,6]. Importantly, α-MSH also blocked IL-6 protein expression in
rat intestinal injury concomitantly with its protective effect [20] underlying the potential thera-
peutical significance of our findings.
In conclusion, the direct protective effect of α-MSH on pro-inflammatory cytokine induced
barrier dysfunction and inflammatory activation in Caco-2 monolayers was investigated for
the first time in this study. We demonstrated the presence of major α-MSH receptor MC1 on
Caco-2 epithelial cells, and a protective effect of the antiinflammatory hormone on TNF-α and
IL-1β treatment induced paracellular barrier opening in parallel with the inhibition of NF-κB
nuclear translocation and polarized secretion of other inflammatory cytokines. These findings
support the therapeutical potential of α-MSH to restore epithelial barrier integrity in inflam-
matory gut diseases.
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